- Palliation in metastatic non-small cell lung cancer: Early integration with standard oncological care is the key. Singh, Navneet; Behera, Digambar // Lung India;Oct-Dec2014, Vol. 31 Issue 4, p317
An introduction is presented in which the editor discusses various reports within the issue on lung cancer treatment including chemotherapy, radiation therapy, and palliative care.
- Palliative Thoracic Radiotherapy in NSCLC. Lester, Jason F. // Current Medical Literature: Lung Cancer;2008, Vol. 1 Issue 4, p105
The article discusses the clinical evidence to guide clinicians in deciding when and how to use palliative thoracic radiotherapy non-small-cell lung carcinoma (NSCLC). Advanced NSCLC is the disease included within a radiotherapy (RT) field but extensive for curative treatment, with no showing of...
- Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial. Falk, Stephen J; Girling, David J; White, Roger J; Hopwood, Penelope; Harvey, Angela; Qian, Wendi; Stephens, Richard J // BMJ: British Medical Journal (International Edition);8/31/2002, Vol. 325 Issue 7362, p465
Abstract Objective: To determine whether patients with locally advanced non-small cell lung cancer unsuitable for resection or radical radiotherapy, and with minimal thoracic symptoms, should be given palliative thoracic radiotherapy immediately or as needed to treat symptoms. Design:...
- Cost-Utility Analysis of Short-Versus Long-Course Palliative Radiotherapy in Patients With Non-Small-Cell Lung Cancer. van den Hout, Wilbert B.; Kramer, Gijsbert W. P. M.; Noordijk, Ed M.; Leer, Jan-Willem H. // JNCI: Journal of the National Cancer Institute;12/20/2006, Vol. 98 Issue 24, p1786
Background: Radiotherapy can effectively palliate the symptoms of poor-prognosis patients with non-small-cell lung cancer. However, controversy remains about whether short-course or more protracted radiotherapy schedules provide better value for the money. We conducted a societal cost-utility...
- Lung Cancer. // Current Medical Literature: Respiratory Medicine;2010, Vol. 24 Issue 4, p110
No abstract available.
- Hypofractionated Radiotherapy in Non Small Cell Lung Cancer: A Review of the Current Literature. Beli, I.; Koukourakis, G.; Platoni, K.; Tolia, M.; Kelekis, N.; Kouvaris, J.; Syrigos, C.; Mystakidou, K.; Varveris, C.; Kouloulias, V. // Reviews on Recent Clinical Trials;May2010, Vol. 5 Issue 2, p103
Hypofractionated irradiation has an established role in the palliative treatment of patients with advanced medically inoperable non - small cell lung cancer (NSCLC) and poor performance status. Also hypofractionated radiotherapy merits careful consideration in the curative treatment of patients...
- In Reply:. Hammerschmidt, Stefan; Wirtz, Hubert // Deutsches Aerzteblatt International;10/15/2010, Vol. 107 Issue 41, p5
A response by Stefan Hammerschmidt and Hubert Wirtz to several letters to the editor about their article "Lung Cancer: Current Diagnosis and Treatment," published in the 2009 issue of the journal is presented.
- Lung cancer treatment and palliation. // Thorax;Dec2004 Supplement, Vol. 59, p52
The article presents some papers related to lung cancer treatment and palliation. Concurrent chemoradiotherapy may be the most effective form of treatment for some patients with locally advanced inoperable non-small cell lung cancer (NSCLC). The causative relationship between thoracic...
- Palliative chemotherapy followed by consolidation radiotherapy in patients with advanced and metastatic non-small cell lung cancer not suitable for radical treatment. Eldeeb, Hany; Camileri, Philip; Mak, Choi // Archive of Oncology;Jul2012, Vol. 20 Issue 1/2, p8
Background: This is a retrospective study to assess the effectiveness of consolidation radiotherapy (CRT) following palliative chemotherapy in patients with metastatic or locally advanced non-small cell lung cancer (NSCLC) who are not suitable for radical treatment. Methods: This study involved...